Fortrea Holdings Inc. (FTRE)
FTRE Stock Price Chart
Explore Fortrea Holdings Inc. interactive price chart. Choose custom timeframes to analyze FTRE price movements and trends.
FTRE Company Profile
Discover essential business fundamentals and corporate details for Fortrea Holdings Inc. (FTRE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jun 2023
Employees
15.00K
Website
https://www.fortrea.comCEO
Peter M. Neupert
Description
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
FTRE Financial Timeline
Browse a chronological timeline of Fortrea Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is $0.15.
Earnings released on 6 Aug 2025
EPS came in at $0.19 surpassing the estimated $0.06 by +216.67%, while revenue for the quarter reached $710.30M , beating expectations by +13.94%.
Earnings released on 12 May 2025
EPS came in at $0.02 surpassing the estimated -$0.07 by +128.57%, while revenue for the quarter reached $651.30M , beating expectations by +6.61%.
Earnings released on 3 Mar 2025
EPS came in at $0.18 falling short of the estimated $0.36 by -50.00%, while revenue for the quarter reached $697.00M , beating expectations by +5.45%.
Earnings released on 8 Nov 2024
EPS came in at $0.23 falling short of the estimated $0.27 by -14.81%, while revenue for the quarter reached $674.90M , missing expectations by -4.12%.
Earnings released on 12 Aug 2024
EPS came in at -$0.03 falling short of the estimated $0.07 by -142.86%, while revenue for the quarter reached $662.40M , missing expectations by -3.87%.
Earnings released on 13 May 2024
EPS came in at -$0.04 falling short of the estimated -$0.01 by -619.42%, while revenue for the quarter reached $662.10M , missing expectations by -12.26%.
Earnings released on 11 Mar 2024
EPS came in at $0.19 falling short of the estimated $0.23 by -17.39%, while revenue for the quarter reached $775.40M , missing expectations by -0.47%.
Earnings released on 13 Nov 2023
EPS came in at $0.24 surpassing the estimated $0.18 by +33.33%, while revenue for the quarter reached $776.40M , beating expectations by +3.67%.
Earnings released on 14 Aug 2023
EPS came in at $0.52 surpassing the estimated $0.39 by +33.33%, while revenue for the quarter reached $793.00M , beating expectations by +2.79%.
Earnings released on 31 Mar 2023
EPS came in at -$0.13 , while revenue for the quarter reached $764.20M .
Earnings released on 31 Dec 2022
EPS came in at $0.45 , while revenue for the quarter reached $3.10B .
Earnings released on 30 Sept 2022
EPS came in at $0.69 , while revenue for the quarter reached $762.30M .
Earnings released on 29 Jun 2022
EPS came in at $0.75 , while revenue for the quarter reached $793.10M .
Earnings released on 30 Mar 2022
EPS came in at $0.37 , while revenue for the quarter reached $779.00M .
FTRE Stock Performance
Access detailed FTRE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.